Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Joe Biden
Payers
Insurers question cell and gene therapy costs as new model nears
Health plans and employers view gene therapy affordability as a challenge, as the CMS rolls out a sickle cell model to improve cost outcomes.
Noah Tong
May 5, 2025 4:00pm
Jill Biden, Milken Institute team up for Women's Health Network
May 1, 2025 5:00pm
Trump imposes Schedule F to more easily remove federal workers
Apr 18, 2025 4:05pm
Trump order seeks changes to drug price negotiation program
Apr 16, 2025 11:08am
HHS updates reg on gender dysphoria as Oz targets Medicaid funds
Apr 11, 2025 4:42pm
Former HHS Secretary Becerra to run for California governor
Apr 2, 2025 2:57pm
